- Home
- HUBC vs PASG Comparison
HUBC vs PASG Comparison
Compare HUBC & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBC
- PASG
- Stock Information
- Founded
- HUBC 2017
- PASG 2017
- Country
- HUBC Israel
- PASG United States
- Employees
- HUBC N/A
- PASG N/A
- Industry
- HUBC
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- HUBC
- PASG Health Care
- Exchange
- HUBC Nasdaq
- PASG Nasdaq
- Market Cap
- HUBC 25.1M
- PASG 20.3M
- IPO Year
- HUBC N/A
- PASG 2020
- Fundamental
- Price
- HUBC $2.20
- PASG $7.55
- Analyst Decision
- HUBC
- PASG Strong Buy
- Analyst Count
- HUBC 0
- PASG 4
- Target Price
- HUBC N/A
- PASG $59.25
- AVG Volume (30 Days)
- HUBC 417.8K
- PASG 32.6K
- Earning Date
- HUBC 11-11-2025
- PASG 11-12-2025
- Dividend Yield
- HUBC N/A
- PASG N/A
- EPS Growth
- HUBC N/A
- PASG N/A
- EPS
- HUBC N/A
- PASG N/A
- Revenue
- HUBC $29,562,000.00
- PASG N/A
- Revenue This Year
- HUBC N/A
- PASG N/A
- Revenue Next Year
- HUBC N/A
- PASG N/A
- P/E Ratio
- HUBC N/A
- PASG N/A
- Revenue Growth
- HUBC N/A
- PASG N/A
- 52 Week Low
- HUBC $1.72
- PASG $5.12
- 52 Week High
- HUBC $14.00
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- HUBC 42.86
- PASG 58.26
- Support Level
- HUBC $2.17
- PASG $6.82
- Resistance Level
- HUBC $2.53
- PASG $7.29
- Average True Range (ATR)
- HUBC 0.20
- PASG 0.46
- MACD
- HUBC 0.02
- PASG 0.01
- Stochastic Oscillator
- HUBC 32.14
- PASG 92.00
About HUBC Hub Cyber Security Ltd.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.